Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Abstract
Epidemiological and clinical data indicate high comorbidity between depression and drug dependence that may reflect an attempt to self-medicate with drugs of abuse. The present review examines whether these two psychiatric disorders are related by attempting to identify similarities in the neurobiology of depression and drug dependence. Emphasis is put on the neuromechanisms that may mediate specific core symptoms of both disorders that reflect alterations in reward and motivational processes. First, the epidemiological and clinical data on the comorbidity of the two disorders are reviewed briefly. Then, the neuroadaptations associated with psychomotor stimulant, opiate, ethanol, nicotine, and benzodiazepine dependence in animals are reviewed. Finally, the neurotransmitter systems whose function appears to be altered in depression (i.e., serotonin, norepinephrine, acetylcholine, dopamine, gamma-aminobutyric acid, corticotropin releasing factor, neuropeptide Y, and somatostatin), as revealed primarily by animal studies, are discussed. It is concluded that drug dependence and depression may be associated with alterations in some of the same neurotransmitter systems and, in particular, with alterations of neurotransmitter function in limbic-related brain structures. Thus, these two psychiatric disorders may be linked by some shared neurobiology. Nevertheless, it remains unclear whether drug abuse and depression are different symptomatic expressions of the same preexisting neurobiological abnormalities, or whether repeated drug abuse leads to the abnormalities mediating depression (i.e., drug-induced depressions). The hypothesis of self-medication of non-drug- and drug-induced depressions with drugs of abuse is also discussed as a potentially important explanatory concept in understanding the observed clinical comorbidity of these two psychiatric disorders.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some depressed patients initiate smoking as an attempt to self-medicate depressive symptoms with nicotine.
“it is believed that some depressed patients initiate smoking as an attempt to self medicate depressive symptoms with nicotine (Markou et al., 1998; Patton et al., 1998).”
From It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood (2008) · cites this paper as Markou et al., 1998
People with depression or anxiety may use nicotine to self-medicate.
“Depression and anxiety are both highly comorbid with nicotine dependence (Paperwalla et al., 2004), and nicotine use may be an attempt at self-medication in these conditions (Markou et al., 1998).”
From Nicotinic Partial Agonists Varenicline and Sazetidine-A Have Differential Effects on Affective Behavior (2010) · cites this paper as Markou et al., 1998
Chronic drug taking leading to hypo-activity of the meso-ventromedial striatal dopamine system may result in a negative mood state which in turn accelerates drug-taking (self-medication) in an attempt to improve the mood state.
“These findings suggest that chronic drug taking leading to hypo-activity of the meso-ventromedial striatal dopamine system may result in a negative mood state which in turn accelerates drug-taking (“self-medication”) in an attempt to improve the mood state (Markou et al., 1998).”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Markou et al., 1998
According to the self-medication hypothesis of nicotine dependence, nicotine reduces negative affect and works as an antidepressant.
“According to the self-medication hypothesis of nicotine dependence (Carmody, 1992; Markou, Kosten, & Koob, 1998; Pomerleau & Pomerleau, 1985), this might be because nicotine reduces negative affect and works as an antidepressant.”
From Nicotine addiction and psychiatric disorders (2015) · cites this paper as Markou et al., 1998
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370 · see citing works
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,143 · see citing works
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · see citing works
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,499 · see citing works
Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events
Kanner, A. D., Coyne, J. C., Schaefer, C. A., & Lazarus, R. S. (1981) · Journal of Behavioral Medicine · doi:10.1007/bf00844845 · Cited by 3,128 · see citing works
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 2,997 · see citing works
Psychiatric disorders in America: the epidemiologic catchment area study
(1991) · Choice Reviews Online · doi:10.5860/choice.28-5931 · Cited by 2,561 · see citing works
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550 · see citing works
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070 · see citing works
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953 · see citing works
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901 · see citing works
The Structured Clinical Interview for DSM-III-R (SCID)
Williams, J. B. W. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080038006 · Cited by 1,627 · see citing works
Six-Month Prevalence of Psychiatric Disorders in Three Communities
Myers, J. K. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210041006 · Cited by 1,573 · see citing works
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · see citing works
5-HIAA in the Cerebrospinal Fluid
Åsberg, M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770100055005 · Cited by 1,448 · see citing works
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415 · see citing works
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378 · see citing works
Selective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. E. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,233 · see citing works
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · see citing works
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207 · see citing works
Norepinephrine in Depressive Reactions
Bunney, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,154 · see citing works
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,143 · see citing works
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134 · see citing works
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113 · see citing works
Stewart, J., de Wit, H., & Eikelboom, R. (1984) · Psychological Review · doi:10.1037//0033-295x.91.2.251 · Cited by 1,064 · see citing works
Stressful life events, genetic liability, and onset of an episode of major depression in women
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.833 · Cited by 1,063 · see citing works
Serotonin Function and the Mechanism of Antidepressant Action
Delgado, P. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170011002 · Cited by 930 · see citing works
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 837 · see citing works
Aghajanian, G. K. (1978) · Nature · doi:10.1038/276186a0 · Cited by 803 · see citing works
Smoking and Major Depression: A Causal Analysis
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130038007 · Cited by 792 · see citing works
Adult Outcomes of Childhood and Adolescent Depression: I. Psychiatric Status
Harrington, R. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170065010 · Cited by 764 · see citing works
On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine
Roberts, D. C. S., Corcoran, M. E., & Fibiger, H. C. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90084-3 · Cited by 728 · see citing works
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723 · see citing works
Development of β-adrenergic receptor subsensitivity by antidepressants
Banerjee, S. P., Kung, L. S., Riggi, S. J., & Chanda, S. K. (1977) · Nature · doi:10.1038/268455a0 · Cited by 722 · see citing works
Tryptophan depletion causes a rapid lowering of mood in normal males
Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985) · Psychopharmacology · doi:10.1007/bf00431803 · Cited by 715 · see citing works
Substance Abuse: A Comprehensive Textbook
Liskow, B. I. (1998) · JAMA · doi:10.1001/jama.279.10.802-a · Cited by 712 · see citing works
Kendler, K. S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170048007 · Cited by 693 · see citing works
Engel, G., G�thert, M., Hoyer, D., Schlicker, E., & Hillenbrand, K. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00633189 · Cited by 677 · see citing works
Psychopathology as a Predictor of Treatment Outcome in Alcoholics
Rounsaville, B. J. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180015002 · Cited by 664 · see citing works
Pettit, H. O., Ettenberg, A., Bloom, F. E., & Koob, G. F. (1984) · Psychopharmacology · doi:10.1007/bf00427441 · Cited by 651 · see citing works
Wikler, A. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750350005001 · Cited by 650 · see citing works
Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment
Charney, D. S. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780350094011 · Cited by 649 · see citing works
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647 · see citing works
The scientific case that nicotine is addictive
Stolerman, I. P., & Jarvis, M. J. (1995) · Psychopharmacology · doi:10.1007/bf02245088 · Cited by 646 · see citing works
An 8-year follow-up of 450 sons of alcoholic and control subjects
Schuckit, M. A. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030020005 · Cited by 627 · see citing works
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605 · see citing works
Psychiatric Diagnoses of Treatment-Seeking Cocaine Abusers
Rounsaville, B. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250045005 · Cited by 605 · see citing works
Vetulani, J., & Sulser, F. (1975) · Nature · doi:10.1038/257495a0 · Cited by 596 · see citing works
Heterogeneity of Psychiatric Diagnosis in Treated Opiate Addicts
Rounsaville, B. J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020027006 · Cited by 565 · see citing works
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · see citing works
Wender, P. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100013003 · Cited by 560 · see citing works
Reduced Corticotropin Releasing Factor Binding Sites in the Frontal Cortex of Suicide Victims
Nemeroff, C. B. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800300075009 · Cited by 555 · see citing works
Markou, A., Weiss, F., Gold, L. H., Caine, S. B., Schulteis, G., & Koob, G. F. (1993) · Psychopharmacology · doi:10.1007/bf02244907 · Cited by 551 · see citing works
Self-citationIncreased Serotonin2 and β-Adrenergic Receptor Binding in the Frontal Cortices of Suicide Victims
Mann, J. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100048007 · Cited by 549 · see citing works
INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS
Stanley, M., & Mann, J. J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92590-4 · Cited by 529 · see citing works
Clarke, P. B. S., & Pert, A. (1985) · Brain Research · doi:10.1016/0006-8993(85)90456-1 · Cited by 527 · see citing works
Rossetti, Z. L., Hmaidan, Y., & GESSA, G. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90706-a · Cited by 526 · see citing works
Mode of action of antidepressant drugs
Sulser, F., Vetulani, J., & Mobley, P. L. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90226-5 · Cited by 515 · see citing works
Artigas, F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030084009 · Cited by 512 · see citing works
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Synapse · doi:10.1002/syn.890160105 · Cited by 510 · see citing works
The Clinical Implications of Primary Diagnostic Groups Among Alcoholics
Schuckit, M. A. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790340021003 · Cited by 506 · see citing works
Postcocaine anhedonia. An animal model of cocaine withdrawal.
Markou, A., & Koob, G. F. (1991) · PubMed · Cited by 505 · see citing works
Self-citationIntracranial self-administration of morphine into the ventral tegmental area in rats
Bozarth, M. A., & Wise, R. A. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90148-x · Cited by 503 · see citing works
Unipolar Depression in Adolescents: Clinical Outcome in Adulthood
Rao, U., Ryan, N. D., Birmaher, B. B., Dahl, R. E., Williamson, D. E., Kaufman, J., Rao, R., & Nelson, B. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199505000-00009 · Cited by 502 · see citing works
Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial
Glassman, A. H. (1988) · JAMA · doi:10.1001/jama.259.19.2863 · Cited by 494 · see citing works
de Wit, H., & Wise, R. A. (1977) · Canadian Journal of Psychology / Revue canadienne de psychologie · doi:10.1037/h0081662 · Cited by 491 · see citing works
Heterogeneity in the Inheritance of Alcoholism
Pickens, R. W. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250021002 · Cited by 480 · see citing works
de Montigny, C., & Aghajanian, G. K. (1978) · Science · doi:10.1126/science.725608 · Cited by 477 · see citing works
Sleep Research in Affective Illness: State of the Art Circa 1987
Reynolds, C. F., & Kupfer, D. J. (1987) · SLEEP · doi:10.1093/sleep/10.3.199 · Cited by 467 · see citing works
Weiss, F., Parsons, L. H., Schulteis, G., Hyytiä, P., Lorang, M. T., Bloom, F. E., & Koob, G. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03474.1996 · Cited by 457 · see citing works
Wolfe, B. B., Harden, T. K., Sporn, J. R., et al. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31441-2 · Cited by 452 · see citing works
Albert, P. R., Zhou, Q., Tol, H. H. M. V., Bunzow, J. R., & Civelli, O. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39437-2 · Cited by 450 · see citing works
REM latency: a psychobiologic marker for primary depressive disease.
Dj, K. (1976) · PubMed · Cited by 445 · see citing works
Nicotine Dependence and Major Depression: New Evidence From a Prospective Investigation
Breslau, N. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130033006 · Cited by 443 · see citing works
Depression: The predisposing influence of stress
Anisman, H., & Zacharko, R. M. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00010633 · Cited by 433 · see citing works
Relapse of depression after rapid depletion of tryptophan
Smith, K., Fairburn, C. G., & Cowen, P. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07044-4 · Cited by 428 · see citing works
Blier, P. U., & de Montigny, C. (1987) · Synapse · doi:10.1002/syn.890010511 · Cited by 426 · see citing works
Arango, V. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230054009 · Cited by 420 · see citing works
A possible common mechanism of action of antidepressant treatments
Vetulani, J., Stawarz, R. J., Dingell, J. V., & Sulser, F. (1976) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499215 · Cited by 413 · see citing works
Changes in depression among abstinent alcoholics
Brown, S. A., & Schuckit, M. A. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.412 · Cited by 412 · see citing works
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407 · see citing works
Wise, R. A., Leeb, K., Pocock, D., Newton, P., Burnette, B., & Justice, J. B. (1995) · Psychopharmacology · doi:10.1007/bf02246140 · Cited by 395 · see citing works
Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
Maldonado, R. J., Stinus, L., Gold, L. H., & Koob, G. F. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11090-2 · Cited by 390 · see citing works
Comparison of induced and independent major depressive disorders in 2,945 alcoholics
Schuckit, M. A., TIPP, J. E., Bergman, M., Reich, W., HESSELBROCK, V. M., & Smith, T. L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.948 · Cited by 387 · see citing works
Heninger, G. R., Delgado, P. L., & Charney, D. S. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979535 · Cited by 381 · see citing works
GABA and mood disorders: a brief review and hypothesis
Petty, F. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00025-i · Cited by 378 · see citing works
The Flinders sensitive line rats: a genetic animal model of depression
Overstreet, D. H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80230-1 · Cited by 369 · see citing works
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats
Yokel, R. A., & Wise, R. A. (1976) · Psychopharmacology · doi:10.1007/bf00496868 · Cited by 369 · see citing works
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357 · see citing works
Neural substrates of opiate withdrawal
Koob, G. F., Maldonado, R. J., & Stinus, L. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90171-4 · Cited by 356 · see citing works
Role of the dopaminergic system in depression
Kapur, S., & Mann, J. J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90137-o · Cited by 350 · see citing works
Mood-Lowering Effect of Tryptophan Depletion
Benkelfat, C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090019003 · Cited by 341 · see citing works
Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats
Roberts, A. J., Cole, M., & Koob, G. F. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01125.x · Cited by 340 · see citing works
Rodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · see citing works
Depression and depressive symptoms in smoking cessation
Covey, L. S., Glassman, A. H., & Stetner, F. (1990) · Comprehensive Psychiatry · doi:10.1016/0010-440x(90)90042-q · Cited by 329 · see citing works
Corticotropin-releasing factor and neuropeptide y: role in emotional integration
Heilig, M. A., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324 · see citing works
Chaput, Y., de Montigny, C., & Blier, P. U. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00500007 · Cited by 323 · see citing works
Weiss, F., Markou, A., Lorang, M. T., & Koob, G. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)91327-b · Cited by 318 · see citing works
Self-citationEffectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression
Blier, P. U., & Bergeron, R. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199506000-00011 · Cited by 318 · see citing works
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317 · see citing works
Arora, R. C., & Meltzer, H. Y. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.730 · Cited by 313 · see citing works
CSF and Urinary Biogenic Amines and Metabolites in Depression and Mania
Koslow, S. H. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790080081011 · Cited by 312 · see citing works
Piecing together the Puzzle of Basal Forebrain Anatomy
Heimer, L., & Alheid, G. F. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-0145-6_1 · Cited by 310 · see citing works
GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats
Hyytiä, P., & Koob, G. F. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00314-b · Cited by 302 · see citing works
Delgado, P. L. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110025005 · Cited by 289 · see citing works
CSF monoamine metabolites in melancholia
Åsberg, M., Bertilsson, L., Mårtensson, B., Scalia‐Tomba, G., Thorén, P., & Träskman‐Bendz, L. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02488.x · Cited by 289 · see citing works
Changes in Mood, Craving, and Sleep During Short-term Abstinence Reported by Male Cocaine Addicts
Weddington, W. W. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210069010 · Cited by 288 · see citing works
Caine, S. B., Heinrichs, S. C., Coffin, V. L., & Koob, G. F. (1995) · Brain Research · doi:10.1016/0006-8993(95)00598-k · Cited by 286 · see citing works
Cerebrospinal Fluid Monoamine Metabolites and Suicidal Behavior in Depressed Patients
Roy, A. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070035005 · Cited by 284 · see citing works
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.656 · Cited by 278 · see citing works
Kreiss, D. S., & Lucki, I. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10650-2 · Cited by 277 · see citing works
Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain
Bergstrom, D. A., & Kellar, K. J. (1979) · Nature · doi:10.1038/278464a0 · Cited by 276 · see citing works
Opponent process theory of motivation: Neurobiological evidence from studies of opiate dependence
Koob, G. F., Stinus, L., Moal, M. L., & Bloom, F. E. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80022-3 · Cited by 268 · see citing works
Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients
Shopsin, B. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770070041003 · Cited by 266 · see citing works
5HT2 receptor changes in major depression
Yates, M., Leake, A., Candy, J., FAIRBAIRN, A. F., McKeith, I. G., & Ferrier, I. N. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90440-d · Cited by 265 · see citing works
Nicotine self-administration in animals and humans: similarities and differences
Rose, J. E., & Corrigall, W. A. (1997) · Psychopharmacology · doi:10.1007/s002130050209 · Cited by 262 · see citing works
Widerlöv, E., Lindström, L., Wahlestedt, C., & Ekman, R. (1988) · Journal of Psychiatric Research · doi:10.1016/0022-3956(88)90030-1 · Cited by 262 · see citing works
Blier, P. U., de Montigny, C., & Chaput, Y. (1990) · PubMed · Cited by 261 · see citing works
METABOLISM OF [3H]NOREPINEPHRINE IN THE RAT BRAIN
Glowinski, J., Kopin, I. J., & Axelrod, J. (1965) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1965.tb10247.x · Cited by 261 · see citing works
Parsons, L. H., Smith, A. D., & Justice, J. B. (1991) · Synapse · doi:10.1002/syn.890090109 · Cited by 260 · see citing works
Fluoxetine reduces intravenous cocaine self-administration in rats
Carroll, M. E., Lac, S. T., Asencio, M., et al. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90232-7 · Cited by 255 · see citing works
Nemeroff, C. B., Bissette, G., Akil, H., & Fink, M. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.1.59 · Cited by 253 · see citing works
Parsons, L. H., & Justice, J. B. (1993) · Brain Research · doi:10.1016/0006-8993(93)90984-u · Cited by 253 · see citing works
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.264.12.1546 · Cited by 251 · see citing works
Chaput, Y., de Montigny, C., & Blier, P. U. (1991) · PubMed · Cited by 249 · see citing works
Self-administration of methionine enkephalin into the nucleus accumbens
Goeders, N. E., Lane, J. D., & Smith, J. E. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90284-3 · Cited by 245 · see citing works
Cerebrospinal Fluid Amine Metabolites in Affective Illness: The Probenecid Technique
Goodwin, F. K., Post, R. M., Dünner, D. L., & Gordon, E. K. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.73 · Cited by 244 · see citing works
Ellenbogen, M. A. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00056-5 · Cited by 242 · see citing works
Spyraki, C., & Fibiger, H. C. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90531-8 · Cited by 238 · see citing works
Hjorth, S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03217.x · Cited by 237 · see citing works
Bel, N., & Artigas, F. (1993) · Synapse · doi:10.1002/syn.890150310 · Cited by 237 · see citing works
Kellar, K. J., Cascio, C. S., Butler, J. A., et al. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90460-x · Cited by 232 · see citing works
Serotonin-facilitated dopamine release in vivo: pharmacological characterization.
Benloucif, S., Keegan, M., & Galloway, M. P. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38133-4 · Cited by 230 · see citing works
Dependence, Tolerance, and Addiction to Benzodiazepines: Clinical and Pharmacokinetic Considerations
Greenblatt, D. J., & Shader, R. I. (1978) · Drug Metabolism Reviews · doi:10.3109/03602537808993775 · Cited by 230 · see citing works
Janowsky, D. S., El-Yousef, K. M., & Davis, J. M. (1974) · Psychosomatic Medicine · doi:10.1097/00006842-197405000-00008 · Cited by 230 · see citing works
Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., & Stinus, L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199501000-00011 · Cited by 226 · see citing works
Alcoholism and Major Depression in Women
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210024003 · Cited by 225 · see citing works
Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens
Pettit, H. O., & Justice, J. B. (1991) · Brain Research · doi:10.1016/0006-8993(91)90690-w · Cited by 225 · see citing works
Loh, E. A., & Roberts, D. C. S. (1990) · Psychopharmacology · doi:10.1007/bf02244137 · Cited by 224 · see citing works
Acquas, E., & Chiara, G. D. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10033.x · Cited by 223 · see citing works
Differential effects of antidepressant treatment on brain monoaminergic receptors
Maggi, A. C., U’Prichard, D. C., & Enna, S. J. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90152-1 · Cited by 222 · see citing works
Svebak, S., Cameron, A., & Levander, S. (1990) · PubMed · Cited by 218 · see citing works
Parsons, L. H., Koob, G. F., & Weiss, F. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10596-x · Cited by 218 · see citing works
McGregor, A., & Roberts, D. C. S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90084-z · Cited by 215 · see citing works
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston‐Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214 · see citing works
Imipramine Treatment of Alcoholics With Primary Depression
McGrath, P. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030054009 · Cited by 212 · see citing works
Gerner, R. H., Fairbanks, L. A., Anderson, G. M., Young, J. G., Scheinin, M., Linnoila, M., Hare, T. A., Shaywitz, B. A., & Cohen, D. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1533 · Cited by 212 · see citing works
3-Methoxy-4-Hydroxy Phenylglycol (MHPG) Excretion in Depressive States
Maas, J. W. (1968) · Archives of General Psychiatry · doi:10.1001/archpsyc.1968.01740080001001 · Cited by 209 · see citing works
Lloyd, K. G., THURET, F., & Pilc, A. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23855-1 · Cited by 206 · see citing works
Elevated CSF CRF in suicide victims
Arató, M., Bánki, C. M., Bissette, G., & Nemeroff, C. B. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90183-2 · Cited by 205 · see citing works
“Perestroika” in the basal forebrain: Opening the border between neurology and psychiatry
Heimer, L., de Olmos, J. S., Alheid, G. F., & Záborszky, L. (1991) · Progress in brain research · doi:10.1016/s0079-6123(08)63050-2 · Cited by 203 · see citing works
Papp, M., Klimek, V., & Willner, P. (1994) · Psychopharmacology · doi:10.1007/bf02245566 · Cited by 202 · see citing works
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb00373.x · Cited by 201 · see citing works
Gardier, A. M., Malagié, I., Trillat, A., Jacquot, C., & Artigas, F. (1996) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1996.tb00145.x · Cited by 198 · see citing works
Yeomans, J. S. (1995) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380235 · Cited by 198 · see citing works
Psychiatric Disorders in Relatives of Probands With Opiate Addiction
Rounsaville, B. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250035004 · Cited by 195 · see citing works
Tóth, E., Sershen, H. W., Hashim, A. T., Vizi, E. S., & Lajtha, Á. (1992) · Neurochemical Research · doi:10.1007/bf00966669 · Cited by 194 · see citing works
Miller, H. L. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020031005 · Cited by 192 · see citing works
Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients
Gerner, R. H., & Yamada, T. (1982) · Brain Research · doi:10.1016/0006-8993(82)90801-0 · Cited by 190 · see citing works
Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
Blackshear, M. A., & Sanders‐Bush, E. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33057-0 · Cited by 189 · see citing works
Psychopathology in Children of Alcoholics
Reich, W., Earls, F. J., FRANKEL, O., & Shayka, J. J. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199309000-00017 · Cited by 188 · see citing works
Romero, L. I. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00240-e · Cited by 185 · see citing works
Delgado, P. L., Price, L. H., Miller, H. L., Salomon, R. M., Licinio, J., Krystal, J. H., Heninger, G. R., & Charney, D. S. (1991) · PubMed · Cited by 184 · see citing works
Selective Activation of Postsynaptic 5-HT1A Receptors Induces Rapid Antidepressant Response
Blier, P. U. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00242-4 · Cited by 184 · see citing works
Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi, F., Howard, R. L., Heinrichs, S. C., Vale, W., Rivier, J., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38740-9 · Cited by 181 · see citing works
Welner, S. A., de Montigny, C., Desroches, J., Desjardins, P., & Suranyi-Cadotte, B. E. (1989) · Synapse · doi:10.1002/syn.890040410 · Cited by 181 · see citing works
Chronic Stress and Major Depression
Breslau, N. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040015003 · Cited by 180 · see citing works
Antidepressants and serotonergic neurotransmission: An integrative review
Willner, P. (1985) · Psychopharmacology · doi:10.1007/bf00429653 · Cited by 179 · see citing works
Blier, P. U., Chaput, Y., & de Montigny, C. (1988) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168834 · Cited by 179 · see citing works
Richardson, N. R., & Roberts, D. C. S. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90248-a · Cited by 178 · see citing works
Mishra, R., Janowsky, A. J., & Sulser, F. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90009-x · Cited by 178 · see citing works
5HT3 receptor antagonists block morphine- and nicotine-but not amphetamine-induced reward
Carboni, E., Acquas, E., Leone, P., & Chiara, G. D. (1989) · Psychopharmacology · doi:10.1007/bf00442245 · Cited by 178 · see citing works
3-methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine
Axelrod, J. L., Kopin, I. J., & Mann, J. D. (1959) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(59)90218-5 · Cited by 177 · see citing works
Heilig, M. A., & Widerlöv, E. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb01366.x · Cited by 176 · see citing works
Janowsky, A. J., Okada, F., Manier, D. H., et al. (1982) · Science · doi:10.1126/science.6291152 · Cited by 176 · see citing works
Ritz, M. C., & Kuhar, M. J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24116-7 · Cited by 176 · see citing works
Cholinergic mechanisms in depression
Dilsaver, S. C. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90016-0 · Cited by 174 · see citing works
Distribution of Serotonin Receptors
Palacios, J. M., Waeber, C., Hoyer, D., & Mengod, G. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16871.x · Cited by 174 · see citing works
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study
Satel, S. L., Price, L. H., Palumbo, J., McDougle, C. J., Krystal, J. H., Gawin, F. H., Charney, D. S., Heninger, G. R., & Kleber, H. D. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.12.1712 · Cited by 173 · see citing works
Clinical Effects of the 5-HT1A Partial Agonists in Depression
Robinson, D. S., Rickels, K., Feighner, J. P., Fabre, L. F., Gammans, R. E., Shrotriya, R. C., Alms, D. R., ANDARY, J. J., & MESSINA, M. E. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199006001-00013 · Cited by 172 · see citing works
Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat
Vaccarino, F. J., Bloom, F. E., & Koob, G. F. (1985) · Psychopharmacology · doi:10.1007/bf00431681 · Cited by 172 · see citing works
Anxiety and depression: a common neurobiological substrate?
Paul, S. M. (1988) · PubMed · Cited by 171 · see citing works
Berman, R., Darnell, A., Miller, H. L., Anand, A., & Charney, D. S. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.37 · Cited by 171 · see citing works
Goodwin, G. M., Green, A. R., & Johnson, P. (1984) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1984.tb10140.x · Cited by 166 · see citing works
The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Ronald Lake, J., Carter, V. A., Scott Cunningham, J., Hebert, K. M., Conrad, D. L., & Wilson, O. B. (1994) · Psychopharmacology · doi:10.1007/bf02244770 · Cited by 165 · see citing works
Kreiss, D. S., & Lucki, I. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38872-5 · Cited by 164 · see citing works
Hyttel, J., Over�, K. F., & Arnt, J. (1984) · Psychopharmacology · doi:10.1007/bf00427416 · Cited by 163 · see citing works
Lam, R. W. M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830010043007 · Cited by 162 · see citing works
Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning
Sugrue, M. F. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90065-7 · Cited by 160 · see citing works
Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats
Acquas, E., Carboni, E., & Chiara, G. D. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90214-b · Cited by 157 · see citing works
Shopsin, B., Gershon, S., Goldstein, M. N., Friedman, E., & Wilk, S. (1975) · PubMed · Cited by 157 · see citing works
Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels
Grant, K. A. (1994) · Behavioural Pharmacology · doi:10.1097/00008877-199408000-00003 · Cited by 156 · see citing works
WOODY, G. E., O’Brien, C. P., & Rickels, K. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.4.447 · Cited by 155 · see citing works
Reduced Neuropeptide Y Concentrations in Suicide Brain
Widdowson, P. S., Ordway, G. A., & Halaris, A. E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08877.x · Cited by 155 · see citing works
Destruction of the locus coeruleus decreases physical signs of opiate withdrawal
Maldonado, R. J., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91364-x · Cited by 155 · see citing works
Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid
Post, R. M., Gordon, E. K., Goodwin, F. K., & Bunney, W. E. (1973) · Science · doi:10.1126/science.179.4077.1002 · Cited by 154 · see citing works
Delgado, P. L., Miller, H., Salomon, R. M., Licinio, J., Heninger, G. R., Gelenberg, A. J., & Charney, D. S. (1993) · PubMed · Cited by 153 · see citing works
Serotonin Receptors in Suicide Victims with Major Depression
Stockmeier, C. A. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00170-4 · Cited by 153 · see citing works
Rutter, J. J., Gundlah, C., & Auerbach, S. B. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90635-1 · Cited by 153 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340 · see citing works
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579 · see citing works
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477 · see citing works
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457 · see citing works
The association of cigarette smoking with depression and anxiety: a systematic review
Fluharty, M., Taylor, A. E., Grabski, M., & Munafò, M. R. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw140 · Cited by 1,299 · see citing works
The neurobiology of anhedonia and other reward-related deficits
Der-Avakian, A., & Markou, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.005 · Cited by 1,130 · see citing works
Self-citationThe psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507 · see citing works
Rehm, J., Room, R., Graham, K., Monteiro, M., Gmel, G., & Sempos, C. T. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00467.x · Cited by 995 · see citing works
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880 · see citing works
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735 · see citing works
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674 · see citing works
Self-citationManagement of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563 · see citing works
Opioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542 · see citing works
Regulation of affect by the lateral septum: implications for neuropsychiatry
Sheehan, T. P., Chambers, R. A., & Russell, D. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.009 · Cited by 514 · see citing works
REVIEW: Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?
Heilig, M., Egli, M., Crabbe, J. C., & Becker, H. C. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00194.x · Cited by 435 · see citing works
PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · see citing works
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424 · see citing works
Chaiton, M. O., Cohen, J. E., O'Loughlin, J., & Rehm, J. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-356 · Cited by 391 · see citing works
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use
Ahmed, S. H., Kenny, P. J., Koob, G. F., & Markou, A. (2002) · Nature Neuroscience · doi:10.1038/nn872 · Cited by 389 · see citing works
Self-citationRemoving Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328 · see citing works
Self-citationReducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis.
Chisholm, D., Rehm, J., Van Ommeren, M., & Monteiro, M. (2004) · Journal of Studies on Alcohol · doi:10.15288/jsa.2004.65.782 · Cited by 326 · see citing works
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · see citing works
Self-citationDrugs as instruments: A new framework for non-addictive psychoactive drug use
Müller, C. P., & Schumann, G. (2011) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11000057 · Cited by 286 · see citing works
Chaki, S., Yoshikawa, R., Hirota, S., Shimazaki, T., Maeda, M., Kawashima, N., Yoshimizu, T., Yasuhara, A., Sakagami, K., Okuyama, S., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.009 · Cited by 254 · see citing works
Ersche, K. D., Turton, A. J., Chamberlain, S. R., Müller, U., Bullmore, E. T., & Robbins, T. W. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11091421 · Cited by 252 · see citing works
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223 · see citing works
Self-citationWatkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · see citing works
Self-citationJackson, K. J., Martin, B. R., Changeux, J. P., & Damaj, M. I. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132977 · Cited by 208 · see citing works
Taylor, A. E., Fluharty, M. E., Bjørngaard, J. H., Gabrielsen, M. E., Skorpen, F., Marioni, R. E., Campbell, A., Engmann, J., Mirza, S. S., Loukola, A., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006141 · Cited by 187 · see citing works
The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy.
Cinciripini, P. M., Wetter, D. W., Fouladi, R. T., Blalock, J. A., Carter, B. L., Cinciripini, L. G., & Baile, W. F. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.2.292 · Cited by 181 · see citing works
Don’t stress about CRF: assessing the translational failures of CRF1antagonists
Spierling, S. R., & Zorrilla, E. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4556-2 · Cited by 170 · see citing works
Pacek, L. R., Martins, S. S., & Crum, R. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.059 · Cited by 164 · see citing works
Ketamine for the treatment of addiction: evidence and potential mechanisms
Ivan Ezquerra-Romano, I., Lawn, W., Krupitsky, E., & Morgan, C. J. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.017 · Cited by 163 · see citing works
Picciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157 · see citing works
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154 · see citing works
Nicotine exposure during adolescence induces a depression-like state in adulthood
Iñiguez, S. D., Warren, B. L., Parise, E. M., Alcantara, L. F., Schuh, B., Maffeo, M. L., Manojlovic, Z., & Bolaños-Guzmán, C. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.220 · Cited by 157 · see citing works
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154 · see citing works
The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors
Kissler, J. L., Sirohi, S., Reis, D. J., Jansen, H. T., Quock, R. M., Smith, D. G., & Walker, B. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.014 · Cited by 145 · see citing works
Dakwar, E., Levin, F., Foltin, R. W., Nunes, E. V., & Hart, C. L. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.009 · Cited by 143 · see citing works
Nealey, K. A., Smith, A. W., Davis, S. M., Smith, D. G., & Walker, B. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.012 · Cited by 133 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Translational assessment of reward and motivational deficits in psychiatric disorders
Der-Avakian, A., Barnes, S. A., Markou, A., & Pizzagalli, D. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5004 · Cited by 122 · see citing works
Self-citationNicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106 · see citing works
Andreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101 · see citing works
Samet, S., Fenton, M. C., Nunes, E., Greenstein, E., Aharonovich, E., & Hasin, D. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04010.x · Cited by 98 · see citing works
Carboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00064-2 · Cited by 96 · see citing works
Dietary creatine intake and depression risk among U.S. adults
Bakian, A. V., Huber, R. S., Scholl, L., Renshaw, P. F., & Kondo, D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0741-x · Cited by 90 · see citing works
Riggs, P. D., Hall, S. K., Mikulich-Gilbertson, S. K., Lohman, M., & Kayser, A. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200404000-00008 · Cited by 89 · see citing works
Turner, J. R., Castellano, L. M., & Blendy, J. A. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166280 · Cited by 88 · see citing works
Zhou, Y., Leri, F., Cummins, E., Hoeschele, M., & Kreek, M. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301419 · Cited by 89 · see citing works
Deficits in a sustained attention task following nicotine withdrawal in rats
Shoaib, M., & Bizarro, L. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2004-6 · Cited by 87 · see citing works
Progesterone modulation of α5 nAChR subunits influences anxiety‐related behavior during estrus cycle
Gangitano, D., Salas, R., Teng, Y., Perez, E., & De Biasi, M. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00476.x · Cited by 76 · see citing works
Nicotine addiction and psychiatric disorders
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65 · see citing works
Slawecki, C. J., Thorsell, A. K., Khoury, A. E., Mathé, A. A., & Ehlers, C. L. (2005) · Neuropeptides · doi:10.1016/j.npep.2005.06.002 · Cited by 64 · see citing works
Guerrero-Hreins, E., Goldstone, A. P., Brown, R. M., & Sumithran, P. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110303 · Cited by 62 · see citing works
Baiamonte, B. A., Valenza, M., Roltsch, E. A., Whitaker, A. M., Baynes, B. B., Sabino, V., & Gilpin, N. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.025 · Cited by 58 · see citing works
Simmons, L. A., & Havens, J. R. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.016 · Cited by 60 · see citing works
Desipramine treatment of cocaine-dependent patients with depression: A placebo-controlled trial
McDowell, D., Nunes, E. V., Seracini, A. M., Rothenberg, J., Vosburg, S. K., Ma, G. J., & Petkova, E. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.03.026 · Cited by 56 · see citing works
Empirical validation of a touchscreen probabilistic reward task in rats
Kangas, B. D., Wooldridge, L. M., Luc, O. T., Bergman, J., & Pizzagalli, D. A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00969-1 · Cited by 47 · see citing works
Translational Assessments of Reward and Anhedonia: A Tribute to Athina Markou
Der-Avakian, A., & Pizzagalli, D. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.008 · Cited by 36 · see citing works
Using Mendelian randomisation to infer causality in depression and anxiety research
Gage, S. H., Smith, G. D., Zammit, S., Hickman, M., & Munafò, M. R. (2013) · Depression and Anxiety · doi:10.1002/da.22150 · Cited by 32 · see citing works
Shahab, L., Gilchrist, G., Hagger-Johnson, G., Shankar, A., West, E., & West, R. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.153494 · Cited by 29 · see citing works
Minder, A. E., Albrecht, D., Schäfer, J., & Zulewski, H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.024 · Cited by 28 · see citing works
Ehlers, C. L., Gilder, D. A., Gizer, I. R., & Wilhelmsen, K. C. (2019) · Addiction · doi:10.1111/add.14431 · Cited by 27 · see citing works
Major depression among adolescent smokers undergoing treatment for nicotine dependence
Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Samuels, D., & Schatzberg, A. F. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.02.029 · Cited by 19 · see citing works
Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress
Brady, K. T., & Sinha, R. (2007) · Focus · doi:10.1176/foc.5.2.foc229 · Cited by 12 · see citing works
- Authors
- Markou, A.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Markou, A
- Venue
- Neuropsychopharmacology
- Published
- 1998-03
- Volume
- 18
- Issue
- 3
- Pages
- 135-174
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W2042152382
- Cited by
- 767
- References
- 456
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 24 · 2023: 21 · 2022: 17 · 2021: 30 · 2020: 22 · 2019: 15 · 2018: 26 · 2017: 21 · 2016: 26 · 2015: 37 · 2014: 28 · 2013: 28 · 2012: 26
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50da004060-13)
- National Institute on Drug Abuse (DA 00213, DA04060, DA 00112)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, drug addiction, self-medication hypothesis, comorbidities, reward and motivation, neurotransmitter systems, limbic system, stimulant use disorder, opioid use disorder, ethanol dependence, nicotine dependence, benzodiazepine dependence, drug-induced depression, serotonin, norepinephrine, dopamine, GABA, neuropeptide Y, somatostatin, corticotropin-releasing factor
- MeSH terms
- Animals, Brain, Corticotropin-Releasing Hormone, Depressive Disorder, Neuropeptide Y, Norepinephrine, Serotonin, Comorbidity, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review